Tadalafil orally disintegrating tablet and preparation method thereof

An orally disintegrating tablet, tadalafil technology, applied in the field of tadalafil orally disintegrating tablets, can solve problems such as inconvenience in taking medicine, unhelpful choice of medication for doctors and patients, inability to achieve natural and satisfactory sexual life, and achieve absorption Fast, high bioavailability, easy to take effect

Inactive Publication Date: 2013-09-04
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
View PDF4 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Up to now, the marketed dosage form of tadalafil is only ordinary tablets, but ordinary tablets need to be taken with water, which is inconvenient to take, and will give patients a psychological hint that they are taking the medicine, which cannot meet the needs of a natural and satisfactory sexual life
Although CN10114314...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tadalafil orally disintegrating tablet and preparation method thereof
  • Tadalafil orally disintegrating tablet and preparation method thereof
  • Tadalafil orally disintegrating tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027]

[0028]

[0029] Preparation:

[0030] Micronize tadalafil and sodium lauryl sulfate, add mannitol, microcrystalline cellulose, croscarmellose sodium and micronized silica gel, mix evenly, add magnesium stearate, mix, and press into tablets.

Embodiment 2

[0032]

[0033] Preparation:

[0034] The tadalafil is micronized, mixed evenly with xylitol, microcrystalline cellulose, aspartame, crospovidone, and micronized silica gel, then added with magnesium stearate, mixed, and compressed into tablets.

Embodiment 3

[0036]

[0037]

[0038] Preparation:

[0039] The tadalafil is micronized, mixed evenly with xylitol, low-substituted hydroxypropyl cellulose, aspartame, citric acid, and crospovidone, then added with magnesium stearate, mixed, and compressed into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a tadalafil orally disintegrating tablet and a preparation method thereof. Aiming to improve the deficiency of existing tadalafil oral dosage forms, the invention provides the tadalafil orally disintegrating tablet which is convenient to take, is quick in absorption, takes effect quickly and has high bioavailability for doctors and patients to help the patients achieve requirements for natural and satisfactory sexual lives. The tadalafil orally disintegrating tablet takes tadalafil or medicinal salts thereof as an active ingredient, contains pharmaceutically acceptable auxiliary materials such as filling agents, disintegrating agents, flavouring agents and lubricating agents, and when being taken, dispenses with water, can be quickly disintegrated or dissolved in oral cavities only in a few seconds and is ingested along with saliva.

Description

technical field [0001] The invention relates to a tadalafil preparation for treating male erectile dysfunction, in particular to a fast-release orally disintegrating tablet of tadalafil. Background technique [0002] Studies have shown that about half of men over the age of 40 suffer from erectile dysfunction (ED), which seriously affects their quality of life. For the pathogenesis of ED, experts and scholars at home and abroad have conducted in-depth research from multiple perspectives. Especially at the level of signal transduction pathway, significant research results have been obtained, and it has been confirmed that NO-cGMP signaling pathway is the key pathway for the pathogenesis of ED. The research results have also been applied clinically. As cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) selective inhibitors such as sildenafil and tadalafil have been used in the treatment of ED Significant clinical effect. [0003] Penile erection ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/20A61K31/4985A61P15/10
Inventor 胡李斌兰菲菲陈浩李巧霞
Owner ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap